Privatklinik Nomo Aalborg ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  34.9% 14.7% 9.6% 5.9% 5.5%  
Credit score (0-100)  1 13 25 38 41  
Credit rating  C BB BB BBB BBB  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  589 1,014 1,009 1,346 1,524  
EBITDA  -211 474 184 302 221  
EBIT  -211 474 184 302 221  
Pre-tax profit (PTP)  -217.1 470.7 173.2 297.1 215.8  
Net earnings  -217.1 414.0 134.2 230.5 165.9  
Pre-tax profit without non-rec. items  -217 471 173 297 216  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -177 237 309 472 383  
Interest-bearing liabilities  0.0 0.0 0.0 24.0 29.6  
Balance sheet total (assets)  375 696 815 1,028 1,010  

Net Debt  -158 -449 -489 -660 -729  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  589 1,014 1,009 1,346 1,524  
Gross profit growth  0.0% 72.3% -0.6% 33.4% 13.2%  
Employees  2 2 2 2 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% 50.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  375 696 815 1,028 1,010  
Balance sheet change%  0.0% 85.6% 17.1% 26.0% -1.7%  
Added value  -211.4 474.1 183.9 302.3 221.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 4.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -35.9% 46.7% 18.2% 22.5% 14.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -38.3% 75.9% 24.4% 32.8% 21.8%  
ROI %  -257.4% 236.3% 58.7% 75.3% 48.9%  
ROE %  -57.9% 135.3% 49.2% 59.1% 38.8%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  -32.1% 34.0% 37.8% 45.9% 37.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  74.9% -94.6% -265.7% -218.1% -329.7%  
Gearing %  0.0% 0.0% 0.0% 5.1% 7.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 46.8% 23.3%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  0.5 1.2 1.3 1.8 1.6  
Current Ratio  0.7 1.7 1.8 2.4 2.0  
Cash and cash equivalent  158.3 448.7 488.7 683.6 758.6  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -145.0 269.0 342.2 572.9 468.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  -106 237 92 151 74  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -106 237 92 151 74  
EBIT / employee  -106 237 92 151 74  
Net earnings / employee  -109 207 67 115 55